CatalystFDA/Bio

UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA

Second CRL for hyperphosphatemia treatment OLC triggers sharp Unicycive stock decline.

What changed

Second CRL for hyperphosphatemia treatment OLC triggers sharp Unicycive stock decline.

Why it matters

Second CRL for hyperphosphatemia treatment OLC triggers sharp Unicycive stock decline. — impact context not separately stored; see What changed.

Sources